Trial Profile
Phase Ib Study of Recombinant Human Serum Albumin/Interferon alpha2a Fusion Protein in Chronic Hepatitis B Patients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Nov 2016
Price :
$35
*
At a glance
- Drugs Albumin interferon alpha 2A fusion protein (Primary) ; Peginterferon alfa-2a
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Beijing Bio-Fortune
- 08 Nov 2016 Results assessing tolerability, pharmacokinetics and antiviral activity of Albumin-interferon-alpha-2A-fusion-protein published in the British Journal of Clinical Pharmacology
- 16 Nov 2014 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 06 Dec 2013 New trial record